Sera Prognostics, Inc.

Sera Prognostics, Inc. is a women's health diagnostic company specializing in developing and commercializing biomarker tests to improve pregnancy outcomes. The company's flagship product, the PreTRM test, is a blood-based biomarker test designed to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. Additionally, Sera Prognostics is working on a range of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression.

Products

• PreTRM test

• Portfolio of product candidates for pregnancy-related conditions